Parnax Lab Limited (BOM:506128)
India
· Delayed Price · Currency is INR 128.60
-1.10 (-0.85%)
At close: Mar 9, 2026
Parnax Lab Revenue
Parnax Lab had revenue of 629.42M INR in the quarter ending December 31, 2025, with 56.51% growth. This brings the company's revenue in the last twelve months to 2.28B, up 23.14% year-over-year. In the fiscal year ending March 31, 2025, Parnax Lab had annual revenue of 1.88B, down -0.54%.
Revenue (ttm)
2.28B
Revenue Growth
+23.14%
P/S Ratio
0.65
Revenue / Employee
190.00M
Employees
12
Market Cap
1.49B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 1.88B | -10.25M | -0.54% |
| Mar 31, 2024 | 1.89B | 211.98M | 12.65% |
| Mar 31, 2023 | 1.68B | 45.75M | 2.81% |
| Mar 31, 2022 | 1.63B | 729.06M | 80.89% |
| Mar 31, 2021 | 901.25M | -54.22M | -5.67% |
| Mar 31, 2020 | Pro | Pro | Pro |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Coral Laboratories | 875.55M |
| Astonea Labs | 1.17B |
| Aayush Wellness | 1.29B |
| Bilcare | 7.40B |
| Lactose (India) | 1.45B |
| Oxygenta Pharmaceutical | 1.13B |
| Pharmaids Pharmaceuticals | 255.33M |
| Ambalal Sarabhai Enterprises | 2.03B |